Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen

P. M. Plezia, David S Alberts, J. F. Kessler, P. L. Berens, J. L. Chase, Denise Roe

Research output: Contribution to journalArticle

Abstract

In a randomized open crossover study, the antiemetic efficacy of a five-drug antiemetic regimen consisting of metoclopramide, dexamethasone, diazepam, diphenhydramine, and thiethylperazine was compared to that of high-dose metoclopramide. Thirteen patients treated with cisplatin combination chemotherapy regimens were evaluated. The study was terminated prior to accrual of the planned number of patients because of the statistically significant difference in efficacy between treatments found at interim analysis. The duration of nausea and number of vomiting episodes on the day of chemotherapy were significantly less (p < 0.01) after receiving the five-drug combination. After receiving the five-drug regimen, 77% of the patients did not experience any episodes of vomiting on day 1, and 8% of patients had only one episode. In contrast, only 31% of patients treated with high-dose metoclopramide did not have any episodes of vomiting on day 1, and 61% of the patients had five or more episodes. None of the patients treated with the five-drug regimen requiring additional antiemetic administration. Although both regimens were, in general, well tolerated, when given the choice of continuing antiemetic therapies, 92% of the patients preferred the five-drug antiemetic combination.

Original languageEnglish (US)
Pages (from-to)101-108
Number of pages8
JournalJournal of Pain and Symptom Management
Volume5
Issue number2
DOIs
StatePublished - 1990

Fingerprint

Metoclopramide
Antiemetics
Vomiting
Drug Combinations
Thiethylperazine
Diphenhydramine
Diazepam
Combination Drug Therapy
Pharmaceutical Preparations
Cross-Over Studies
Nausea
Dexamethasone
Cisplatin
Drug Therapy

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Neurology
  • Nursing(all)

Cite this

Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen. / Plezia, P. M.; Alberts, David S; Kessler, J. F.; Berens, P. L.; Chase, J. L.; Roe, Denise.

In: Journal of Pain and Symptom Management, Vol. 5, No. 2, 1990, p. 101-108.

Research output: Contribution to journalArticle

@article{e3c6b93086c34f75b8d115d9c9ea8108,
title = "Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen",
abstract = "In a randomized open crossover study, the antiemetic efficacy of a five-drug antiemetic regimen consisting of metoclopramide, dexamethasone, diazepam, diphenhydramine, and thiethylperazine was compared to that of high-dose metoclopramide. Thirteen patients treated with cisplatin combination chemotherapy regimens were evaluated. The study was terminated prior to accrual of the planned number of patients because of the statistically significant difference in efficacy between treatments found at interim analysis. The duration of nausea and number of vomiting episodes on the day of chemotherapy were significantly less (p < 0.01) after receiving the five-drug combination. After receiving the five-drug regimen, 77{\%} of the patients did not experience any episodes of vomiting on day 1, and 8{\%} of patients had only one episode. In contrast, only 31{\%} of patients treated with high-dose metoclopramide did not have any episodes of vomiting on day 1, and 61{\%} of the patients had five or more episodes. None of the patients treated with the five-drug regimen requiring additional antiemetic administration. Although both regimens were, in general, well tolerated, when given the choice of continuing antiemetic therapies, 92{\%} of the patients preferred the five-drug antiemetic combination.",
author = "Plezia, {P. M.} and Alberts, {David S} and Kessler, {J. F.} and Berens, {P. L.} and Chase, {J. L.} and Denise Roe",
year = "1990",
doi = "10.1016/S0885-3924(05)80023-5",
language = "English (US)",
volume = "5",
pages = "101--108",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen

AU - Plezia, P. M.

AU - Alberts, David S

AU - Kessler, J. F.

AU - Berens, P. L.

AU - Chase, J. L.

AU - Roe, Denise

PY - 1990

Y1 - 1990

N2 - In a randomized open crossover study, the antiemetic efficacy of a five-drug antiemetic regimen consisting of metoclopramide, dexamethasone, diazepam, diphenhydramine, and thiethylperazine was compared to that of high-dose metoclopramide. Thirteen patients treated with cisplatin combination chemotherapy regimens were evaluated. The study was terminated prior to accrual of the planned number of patients because of the statistically significant difference in efficacy between treatments found at interim analysis. The duration of nausea and number of vomiting episodes on the day of chemotherapy were significantly less (p < 0.01) after receiving the five-drug combination. After receiving the five-drug regimen, 77% of the patients did not experience any episodes of vomiting on day 1, and 8% of patients had only one episode. In contrast, only 31% of patients treated with high-dose metoclopramide did not have any episodes of vomiting on day 1, and 61% of the patients had five or more episodes. None of the patients treated with the five-drug regimen requiring additional antiemetic administration. Although both regimens were, in general, well tolerated, when given the choice of continuing antiemetic therapies, 92% of the patients preferred the five-drug antiemetic combination.

AB - In a randomized open crossover study, the antiemetic efficacy of a five-drug antiemetic regimen consisting of metoclopramide, dexamethasone, diazepam, diphenhydramine, and thiethylperazine was compared to that of high-dose metoclopramide. Thirteen patients treated with cisplatin combination chemotherapy regimens were evaluated. The study was terminated prior to accrual of the planned number of patients because of the statistically significant difference in efficacy between treatments found at interim analysis. The duration of nausea and number of vomiting episodes on the day of chemotherapy were significantly less (p < 0.01) after receiving the five-drug combination. After receiving the five-drug regimen, 77% of the patients did not experience any episodes of vomiting on day 1, and 8% of patients had only one episode. In contrast, only 31% of patients treated with high-dose metoclopramide did not have any episodes of vomiting on day 1, and 61% of the patients had five or more episodes. None of the patients treated with the five-drug regimen requiring additional antiemetic administration. Although both regimens were, in general, well tolerated, when given the choice of continuing antiemetic therapies, 92% of the patients preferred the five-drug antiemetic combination.

UR - http://www.scopus.com/inward/record.url?scp=0025301832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025301832&partnerID=8YFLogxK

U2 - 10.1016/S0885-3924(05)80023-5

DO - 10.1016/S0885-3924(05)80023-5

M3 - Article

C2 - 2189929

VL - 5

SP - 101

EP - 108

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 2

ER -